— Know what they know.
Not Investment Advice

HIMS NYSE

Hims & Hers Health, Inc.
1W: -0.9% 1M: -17.2% 3M: +53.6% YTD: -28.1% 1Y: -60.8% 3Y: +129.1% 5Y: +171.6%
$23.75
-0.26 (-1.08%)
 
Weekly Expected Move ±12.7%
$19 $22 $25 $28 $31
NYSE · Healthcare · Medical - Equipment & Services · Alpha Radar Sell · Power 29 · $5.2B mcap · 206M float · 17.41% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.1 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 2.0%  ·  5Y Avg: -25.7%
Cost Advantage
59
Intangibles
37
Switching Cost
44
Network Effect
60
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HIMS shows a Weak competitive edge (53.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 2.0% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$23
Low
$29
Avg Target
$35
High
Based on 4 analysts since May 11, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 13Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$24.27
Analysts13
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 UBS $35 $23 -12 -3.7% $23.88
2026-05-12 Jefferies $18 $24 +6 -3.1% $25.28
2026-05-12 UBS $32 $35 +3 +38.8% $25.22
2026-05-12 Canaccord Genuity $68 $32 -36 +9.8% $29.14
2026-05-05 Deutsche Bank George Hill $28 $25 -3 -4.5% $26.19
2026-03-10 Deutsche Bank $31 $28 -3 +19.3% $23.47
2026-03-09 Needham Ryan MacDonald $65 $30 -35 +34.2% $22.35
2026-03-09 Oppenheimer Initiated $12 -42.1% $21.58
2026-02-24 Barclays $48 $25 -23 +57.2% $15.90
2026-02-24 Morgan Stanley Craig Hettenbach $40 $21 -19 +46.0% $14.38
2026-02-24 Evercore ISI Initiated $24 +70.2% $14.10
2026-02-24 Truist Financial Jailendra Singh $37 $18 -19 +16.1% $15.51
2026-02-24 Leerink Partners $20 $18 -2 +12.8% $15.51
2026-02-10 Deutsche Bank George Hill $23 $31 +8 +69.8% $18.25
2026-02-09 Leerink Partners Michael Cherny $41 $20 -21 +15.3% $17.35
2026-02-02 BTIG Initiated $60 +121.5% $27.09
2026-01-08 Wolfe Research Initiated $29 -18.2% $35.46
2025-12-08 Barclays Initiated $48 +22.7% $39.12
2025-12-04 Leerink Partners Michael Cherny $46 $41 -5 +1.9% $40.23
2025-11-12 Morgan Stanley Craig Hettenbach Initiated $40 +0.6% $39.75
2025-11-04 Seaport Global Initiated $59 +32.0% $44.71
2025-11-04 Truist Financial Jailendra Singh $45 $37 -8 -17.3% $44.73
2025-11-04 UBS $30 $32 +2 -27.9% $44.39
2025-11-04 Leerink Partners Michael Cherny $26 $46 +20 +3.6% $44.39
2025-06-24 Truist Financial Jailendra Singh $23 $45 +22 +4.8% $42.95
2025-06-23 UBS Initiated $30 -28.5% $41.98
2025-06-04 Needham Ryan Macdonald $28 $65 +37 +21.2% $53.61
2025-02-19 Canaccord Genuity Maria Ripps $38 $68 +30 -1.1% $68.74
2024-12-02 Canaccord Genuity Maria Ripps $24 $38 +14 +23.3% $30.81
2024-11-05 Piper Sandler Korinne Wolfmeyer $13 $21 +8 +1.7% $20.64
2024-11-05 Needham Ryan MacDonald Initiated $28 +33.6% $20.96
2024-10-29 Leerink Partners Michael Cherny $5 $26 +21 +12.7% $23.08
2024-10-21 Bank of America Securities Michael Cherny $23 $25 +2 +12.9% $22.15
2024-10-14 Bank of America Securities Michael Cherny $20 $23 +3 +16.0% $19.82
2024-10-14 Truist Financial Jailendra Singh $13 $23 +10 +16.0% $19.82
2024-09-13 Bank of America Securities Allen Lutz Initiated $20 +26.4% $15.82
2024-08-27 Citigroup Daniel Grosslight Initiated $20 +34.0% $14.93
2024-08-07 Jefferies Glen Santangelo $14 $18 +4 +12.2% $16.04
2024-08-06 Deutsche Bank George Hill $16 $23 +7 +36.3% $16.88
2024-05-22 Canaccord Genuity Maria Ripps $20 $24 +4 +36.7% $17.56
2024-05-07 Jefferies Glen Santangelo $15 $14 -1 +13.4% $12.35
2024-05-07 Truist Financial Jailendra Singh Initiated $13 +4.8% $12.40
2024-05-07 Piper Sandler Korinne Wolfmeyer $6 $13 +7 +5.0% $12.38
2024-05-07 Deutsche Bank George Hill Initiated $16 +37.3% $11.65
2024-04-15 Jefferies Glen Santangelo Initiated $15 +13.5% $13.22
2024-04-10 Canaccord Genuity Maria Ripps Initiated $20 +37.5% $14.55
2022-08-10 Credit Suisse Initiated $8 +21.9% $6.57
2022-08-09 Leerink Partners Initiated $5 -25.5% $6.71
2022-05-26 Piper Sandler Initiated $6 +67.1% $3.59

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HIMS receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-11 C+ D+
2026-05-04 B- C+
2026-04-01 C+ B-
2026-01-03 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

33 Grade D
Profitability
15
Balance Sheet
52
Earnings Quality
41
Growth
52
Value
21
Momentum
50
Safety
80
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HIMS scores highest in Safety (80/100) and lowest in Profitability (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.04
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
1.29
Possible Manipulator
Ohlson O-Score
-5.54
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
A-
Score: 69.5/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -21.43x
Accruals: -20.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HIMS scores 3.04, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HIMS scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HIMS's score of 1.29 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HIMS's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HIMS receives an estimated rating of A- (score: 69.5/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-409.78x
PEG
3.84x
P/S
2.20x
P/B
12.16x
P/FCF
62.51x
P/OCF
16.71x
EV/EBITDA
54.36x
EV/Revenue
2.29x
EV/EBIT
171.40x
EV/FCF
71.56x
Earnings Yield
-0.28%
FCF Yield
1.60%
Shareholder Yield
1.90%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. HIMS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.347
NI / EBT
×
Interest Burden
-1.204
EBT / EBIT
×
EBIT Margin
0.013
EBIT / Rev
×
Asset Turnover
1.656
Rev / Assets
×
Equity Multiplier
2.813
Assets / Equity
=
ROE
-2.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HIMS's ROE of -2.6% is driven by Asset Turnover (1.656), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.35 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1682 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$23.73
Median 1Y
$20.30
5th Pctile
$5.84
95th Pctile
$70.34
Ann. Volatility
76.7%
Analyst Target
$24.27
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Mr. Elshenawy Technology
nology Officer
$375,000 $57,216,276 $60,869,746
Mr. Dudum
Chief Executive Officer and Chairman
$494,792 $10,635,352 $22,958,907
Mr. Kabbani Operating
ief Operating Officer
$227,273 $13,486,199 $14,862,305
Mr. Okupe Financial
ancial Officer
$530,875 $7,473,689 $8,398,808
Ms. Baird Operating
ief Operating Officer
$341,292 $8,048,579 $8,392,871
Mr. Chi Operating
rating Officer (previously Chief Commercial Officer)
$485,000 $6,898,799 $7,727,713
Ms. Boughton Legal
Legal Officer
$464,375 $4,024,269 $4,796,709

CEO Pay Ratio

47:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $22,958,907
Avg Employee Cost (SGA/emp): $488,133
Employees: 2,442

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,442
+49.2% YoY
Revenue / Employee
$961,358
Rev: $2,347,637,000
Profit / Employee
$52,566
NI: $128,365,000
SGA / Employee
$488,133
Avg labor cost proxy
R&D / Employee
$61,139
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 50.8% 57.9% -1.1% -77.2% -88.5% -91.5% -20.3% -18.4% -14.5% -11.0% -7.2% -0.7% 5.5% 30.9% 30.7% 40.1% 47.2% 32.6% 25.2% -2.6% -2.60%
ROA -75.1% -85.7% -39.9% -26.9% -30.8% -31.9% -16.7% -15.1% -11.9% -9.1% -5.8% -0.6% 4.5% 25.1% 21.9% 28.6% 33.7% 23.3% 9.0% -0.9% -0.92%
ROIC 23.6% 31.4% -97.9% -71.1% -73.5% -66.9% -39.5% -36.2% -29.9% -23.4% -17.5% 28.6% 7.7% 63.3% 57.9% 80.3% 93.0% 64.1% 8.9% 2.0% 2.01%
ROCE -71.5% -92.6% -36.5% -27.3% -28.1% -25.9% -21.6% -19.8% -16.4% -12.8% -8.4% -2.3% 3.4% 12.2% 12.7% 22.6% 25.8% 23.7% 6.1% 1.8% 1.81%
Gross Margin 77.9% 74.0% 73.3% 73.8% 76.8% 79.0% 79.1% 80.4% 81.8% 82.6% 82.7% 82.4% 81.3% 79.2% 76.8% 73.5% 76.4% 73.8% 71.9% 49.4% 49.38%
Operating Margin -28.7% -37.3% -25.5% -16.7% -17.8% -13.8% -6.9% -5.9% -4.4% -3.8% -0.2% 3.6% 3.5% 5.6% 3.9% 9.9% 4.9% 2.0% 1.5% -2.7% -2.71%
Net Margin -15.1% -21.5% -36.8% -16.0% -17.3% -13.0% -6.5% -5.3% -3.4% -3.3% 0.5% 4.0% 4.2% 18.8% 5.4% 8.4% 7.8% 2.6% 3.3% -15.1% -15.15%
EBITDA Margin -27.8% -35.2% -35.0% -15.0% -16.2% -12.5% -5.7% -4.8% -3.3% -2.7% 0.9% 4.6% 4.6% 6.7% 5.1% 11.3% 6.8% 5.0% 4.4% 0.9% 0.90%
FCF Margin -8.6% -15.9% -14.5% -13.5% -13.5% -6.5% -6.4% -1.0% 1.6% 3.4% 5.4% 5.4% 8.4% 12.0% 13.4% 13.3% 5.9% 5.9% 3.1% 3.2% 3.20%
OCF Margin -6.4% -13.8% -12.7% -11.8% -12.0% -5.2% -5.0% 0.4% 3.6% 5.7% 8.4% 9.4% 11.9% 15.0% 17.0% 18.7% 13.0% 14.7% 12.9% 12.0% 11.97%
ROE 3Y Avg snapshot only 10.45%
ROE 5Y Avg snapshot only -1.88%
ROA 3Y Avg snapshot only 7.36%
ROIC Economic snapshot only 1.40%
Cash ROA snapshot only 13.16%
Cash ROIC snapshot only 23.11%
CROIC snapshot only 6.18%
NOPAT Margin snapshot only 1.04%
Pretax Margin snapshot only -1.61%
R&D / Revenue snapshot only 7.02%
SGA / Revenue snapshot only 52.49%
SBC / Revenue snapshot only 4.66%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -29.17 -18.46 -12.25 -14.90 -11.13 -13.33 -20.12 -34.54 -41.71 -37.03 -79.28 -1509.26 261.86 42.76 46.18 44.33 66.12 105.43 62.76 -358.19 -409.784
P/S Ratio 10.67 6.60 4.85 3.37 2.47 2.58 2.51 3.33 2.76 1.67 2.14 3.70 4.44 3.49 3.94 4.08 6.36 6.38 3.43 2.00 2.200
P/B Ratio -14.23 -10.27 3.94 3.23 2.76 3.42 4.24 6.59 6.28 4.24 5.43 10.31 13.78 12.59 12.21 15.29 26.85 29.59 14.89 8.76 12.156
P/FCF -124.28 -41.45 -33.46 -24.91 -18.26 -39.44 -39.12 -336.58 168.50 49.18 39.72 68.37 52.96 28.94 29.35 30.81 107.11 107.23 110.57 62.51 62.511
P/OCF 872.54 76.61 29.52 25.40 39.50 37.44 23.19 23.18 21.80 48.93 43.39 26.55 16.71 16.712
EV/EBITDA -27.46 -15.13 -8.93 -9.55 -7.64 -11.12 -18.74 -34.07 -40.86 -36.09 -83.04 1580.13 191.57 72.78 70.03 52.91 80.84 87.49 54.46 54.36 54.356
EV/Revenue 10.16 6.16 3.96 2.61 1.83 2.03 2.18 3.05 2.51 1.45 1.90 3.48 4.24 3.32 3.75 3.92 6.21 6.25 3.72 2.29 2.290
EV/EBIT -26.88 -14.69 -8.64 -8.99 -7.10 -10.23 -16.70 -29.83 -34.27 -28.22 -56.21 -402.71 378.11 96.00 89.36 63.68 99.62 119.68 82.45 171.40 171.398
EV/FCF -118.32 -38.70 -27.33 -19.34 -13.48 -31.11 -33.96 -308.03 153.51 42.70 35.23 64.30 50.61 27.53 27.89 29.59 104.69 105.03 119.99 71.56 71.560
Earnings Yield -3.4% -5.4% -8.2% -6.7% -9.0% -7.5% -5.0% -2.9% -2.4% -2.7% -1.3% -0.1% 0.4% 2.3% 2.2% 2.3% 1.5% 0.9% 1.6% -0.3% -0.28%
FCF Yield -0.8% -2.4% -3.0% -4.0% -5.5% -2.5% -2.6% -0.3% 0.6% 2.0% 2.5% 1.5% 1.9% 3.5% 3.4% 3.2% 0.9% 0.9% 0.9% 1.6% 1.60%
PEG Ratio snapshot only 3.842
Price/Tangible Book snapshot only 71.303
EV/OCF snapshot only 19.132
EV/Gross Profit snapshot only 3.386
Acquirers Multiple snapshot only 173.679
Shareholder Yield snapshot only 1.90%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.43 7.43 3.41 3.41 3.41 3.41 4.52 4.52 4.52 4.52 3.00 3.00 3.00 3.00 1.79 1.79 1.79 1.79 1.90 1.90 1.898
Quick Ratio 7.19 7.19 3.24 3.24 3.24 3.24 4.07 4.07 4.07 4.07 2.74 2.74 2.74 2.74 1.50 1.50 1.50 1.50 1.61 1.61 1.612
Debt/Equity -0.00 -0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 2.34 2.34 2.336
Net Debt/Equity -0.72 -0.72 -0.72 -0.72 -0.56 -0.56 -0.56 -0.56 -0.61 -0.61 -0.61 -0.61 -0.61 -0.61 -0.61 -0.61 1.27 1.27 1.269
Debt/Assets 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.59 0.59 0.587
Debt/EBITDA -0.00 -0.00 -0.05 -0.06 -0.06 -0.07 -0.09 -0.10 -0.12 -0.17 -0.50 4.71 0.42 0.18 0.14 0.09 0.07 0.07 7.87 12.66 12.658
Net Debt/EBITDA 1.38 1.08 2.00 2.75 2.71 2.98 2.85 3.16 3.99 5.48 10.58 -99.92 -8.93 -3.73 -3.66 -2.18 -1.87 -1.83 4.27 6.87 6.874
Interest Coverage
Equity Multiplier -0.81 -0.81 1.26 1.26 1.26 1.26 1.18 1.18 1.18 1.18 1.28 1.28 1.28 1.28 1.48 1.48 1.48 1.48 3.98 3.98 3.983
Cash Ratio snapshot only 1.428
Cash to Debt snapshot only 0.457
FCF to Debt snapshot only 0.060
Defensive Interval snapshot only 141.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 2.05 2.40 1.01 1.19 1.39 1.65 1.34 1.57 1.81 2.01 2.16 2.38 2.64 3.08 2.57 3.11 3.51 3.85 1.64 1.66 1.656
Inventory Turnover 11.62 14.01 7.88 9.58 11.09 12.39 6.73 7.35 7.99 8.51 7.13 7.67 8.63 10.65 6.98 9.43 11.03 12.72 6.82 8.51 8.512
Receivables Turnover 243.38 284.21 125.67 148.31 172.75 205.41 154.79 181.07 208.79 232.84 174.77 192.28 213.88 248.92 230.20 278.20 313.93 344.71 122.82 123.98 123.976
Payables Turnover 5.90 7.11 4.86 5.91 6.85 7.65 4.55 4.96 5.40 5.74 4.16 4.48 5.04 6.21 4.52 6.10 7.14 8.23 5.24 6.54 6.541
DSO 1 1 3 2 2 2 2 2 2 2 2 2 2 1 2 1 1 1 3 3 2.9 days
DIO 31 26 46 38 33 29 54 50 46 43 51 48 42 34 52 39 33 29 54 43 42.9 days
DPO 62 51 75 62 53 48 80 74 68 64 88 82 72 59 81 60 51 44 70 56 55.8 days
Cash Conversion Cycle -29 -24 -26 -21 -18 -16 -24 -22 -20 -19 -34 -32 -28 -23 -27 -20 -17 -15 -13 -10 -10.0 days
Fixed Asset Turnover snapshot only 5.278
Operating Cycle snapshot only 45.8 days
Cash Velocity snapshot only 4.103
Capital Intensity snapshot only 0.909
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 1.2% 73.1% 82.8% 87.6% 90.9% 94.4% 93.8% 92.1% 90.2% 78.3% 65.5% 55.7% 50.1% 56.7% 69.3% 86.0% 88.7% 78.0% 59.0% 32.8% 32.81%
Net Income -2.7% -2.2% -4.9% -14.2% -15.9% -5.1% 39.0% 17.9% 43.4% 58.5% 64.1% 96.0% 1.4% 3.8% 6.4% 70.9% 9.7% 32.1% 1.8% -1.1% -1.08%
EPS 31.9% 42.4% -1.3% 13.7% -9.0% -2.5% 40.4% 19.7% 44.6% 59.4% 64.8% 96.4% 1.3% 3.5% 5.7% 66.0% 8.8% 24.9% -1.2% -1.1% -1.09%
FCF 7.1% -1.3% -4.9% -1.5% -2.0% 20.2% 14.3% 85.9% 1.2% 1.9% 2.4% 9.5% 6.7% 4.6% 3.2% 3.6% 33.5% -12.1% -63.3% -67.9% -67.93%
EBITDA -2.9% -2.8% -7.6% -56.0% -23.2% 12.7% 49.3% 37.1% 51.1% 60.9% 67.4% 1.0% 1.5% 2.8% 5.0% 61.6% 5.5% 1.8% 1.0% -24.5% -24.51%
Op. Income -2.6% -3.1% -6.6% -45.7% -17.0% 19.8% 40.3% 24.5% 39.7% 48.3% 57.1% 86.9% 1.2% 2.1% 3.1% 14.3% 9.5% 1.7% 70.6% -71.6% -71.57%
OCF Growth snapshot only -15.16%
Asset Growth snapshot only 2.05%
Equity Growth snapshot only 13.47%
Debt Growth snapshot only 110.39%
Shares Change snapshot only -7.40%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.8% 1.2% 98.6% 81.7% 80.3% 77.7% 76.0% 75.8% 75.8% 77.2% 75.3% 70.7% 64.5% 56.7% 56.66%
Revenue 5Y 1.3% 1.0% 85.9% 75.7% 73.6% 69.2% 69.18%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 2.0% 1.4% 1.1% 90.7% 86.9% 83.0% 79.9% 79.5% 79.0% 79.2% 76.5% 69.8% 61.9% 48.7% 48.71%
Gross Profit 5Y 1.4% 1.1% 90.3% 78.0% 73.8% 65.5% 65.51%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y 3.9% 3.94%
OCF 5Y
Assets 3Y 71.9% 71.9% 71.9% 71.9% 54.9% 54.9% 54.9% 54.9% 18.9% 18.9% 18.9% 18.9% 80.5% 80.5% 80.51%
Assets 5Y 57.9% 57.9% 57.9% 57.9% 78.6% 78.6% 78.56%
Equity 3Y 12.5% 12.5% 12.5% 12.5% 20.2% 20.2% 20.17%
Book Value 3Y 6.0% 5.4% 4.2% 5.5% 13.0% 16.3% 16.32%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 0.99 0.98 0.95 0.96 0.95 0.94 0.94 0.96 0.97 0.98 0.98 0.89 0.86 0.85 0.86 0.89 0.92 0.923
Earnings Stability 0.80 0.87 0.88 0.80 0.52 0.51 0.19 0.02 0.07 0.03 0.15 0.39 0.24 0.44 0.51 0.63 0.64 0.37 0.374
Margin Stability 0.89 0.92 0.93 0.95 0.90 0.92 0.93 0.94 0.95 0.95 0.96 0.96 0.89 0.91 0.93 0.94 0.95 0.93 0.928
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.94 0.94 0.98 0.84 0.93 0.83 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.20 0.200
Earnings Smoothness 0.00 0.72 0.98
ROE Trend 0.20 0.20 0.25 0.48 0.40 0.44 0.46 0.19 0.14 -0.19 -0.193
Gross Margin Trend 0.08 0.04 0.02 0.03 0.03 0.04 0.04 0.05 0.06 0.06 0.05 0.02 -0.00 -0.04 -0.05 -0.06 -0.07 -0.12 -0.121
FCF Margin Trend 0.10 0.07 0.01 0.08 0.03 0.11 0.13 0.15 0.16 0.13 0.14 0.14 0.14 0.11 0.01 -0.02 -0.06 -0.06 -0.061
Sustainable Growth Rate 5.5% 30.9% 30.7% 40.1% 47.2% 32.6% 25.2%
Internal Growth Rate 4.7% 33.5% 28.1% 40.1% 50.8% 30.4% 9.9%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.17 0.39 0.32 0.52 0.54 0.27 0.40 -0.04 -0.54 -1.25 -3.12 -38.21 6.99 1.84 1.99 2.03 1.35 2.43 2.36 -21.43 -21.433
FCF/OCF 1.35 1.15 1.15 1.15 1.13 1.27 1.27 -2.59 0.45 0.60 0.64 0.58 0.71 0.80 0.79 0.71 0.46 0.40 0.24 0.27 0.267
FCF/Net Income snapshot only -5.730
OCF/EBITDA snapshot only 2.841
CapEx/Revenue 2.2% 2.1% 1.8% 1.7% 1.5% 1.4% 1.4% 1.4% 2.0% 2.3% 3.0% 4.0% 3.5% 3.0% 3.6% 5.5% 7.1% 8.8% 9.8% 8.8% 8.77%
CapEx/Depreciation snapshot only 3.048
Accruals Ratio -0.62 -0.53 -0.27 -0.13 -0.14 -0.23 -0.10 -0.16 -0.18 -0.20 -0.24 -0.23 -0.27 -0.21 -0.22 -0.30 -0.12 -0.33 -0.12 -0.21 -0.207
Sloan Accruals snapshot only 0.084
Cash Flow Adequacy snapshot only 1.365
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 2.7% 77.1% 65.9% 33.4% 18.1% 10.8% 70.1%
Div. Increase Streak
Chowder Number
Buyback Yield 1.1% 1.5% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 1.0% 1.8% 1.4% 0.8% 0.3% 0.1% 1.1% 1.9% 1.90%
Net Buyback Yield -12.0% -16.6% -19.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 1.0% 1.8% 1.4% 0.8% 0.2% -0.0% 0.8% 1.3% 1.31%
Total Shareholder Return -12.0% -16.6% -19.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 1.0% 1.8% 1.4% 0.8% 0.2% -0.0% 0.8% 1.3% 1.31%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 0.96 0.97 0.96 0.96 1.00 1.00 1.00 1.01 1.03 1.09 -4.58 0.86 1.96 1.76 1.37 1.39 1.05 1.04 0.35 0.347
Interest Burden (EBT/EBIT) 0.97 0.88 0.89 0.81 0.90 0.97 0.96 0.94 0.90 0.86 0.73 -0.06 1.76 1.20 1.16 1.09 1.11 1.11 1.17 -1.20 -1.204
EBIT Margin -0.38 -0.42 -0.46 -0.29 -0.26 -0.20 -0.13 -0.10 -0.07 -0.05 -0.03 -0.01 0.01 0.03 0.04 0.06 0.06 0.05 0.05 0.01 0.013
Asset Turnover 2.05 2.40 1.01 1.19 1.39 1.65 1.34 1.57 1.81 2.01 2.16 2.38 2.64 3.08 2.57 3.11 3.51 3.85 1.64 1.66 1.656
Equity Multiplier -0.68 -0.68 2.87 2.87 2.87 2.87 1.22 1.22 1.22 1.22 1.23 1.23 1.23 1.23 1.40 1.40 1.40 1.40 2.81 2.81 2.813
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.37 $-0.41 $-0.53 $-0.36 $-0.41 $-0.42 $-0.32 $-0.29 $-0.23 $-0.17 $-0.11 $-0.01 $0.08 $0.43 $0.52 $0.67 $0.75 $0.54 $0.52 $-0.06 $-0.06
Book Value/Share $-0.77 $-0.73 $1.66 $1.65 $1.64 $1.63 $1.51 $1.50 $1.50 $1.48 $1.64 $1.50 $1.47 $1.46 $1.98 $1.93 $1.86 $1.92 $2.18 $2.37 $1.95
Tangible Book/Share $-0.77 $-0.73 $0.98 $0.98 $0.97 $0.96 $0.87 $0.86 $0.86 $0.85 $1.02 $0.94 $0.91 $0.91 $1.33 $1.30 $1.25 $1.29 $0.27 $0.29 $0.29
Revenue/Share $1.02 $1.14 $1.35 $1.58 $1.83 $2.17 $2.56 $2.98 $3.41 $3.77 $4.16 $4.18 $4.55 $5.28 $6.13 $7.24 $7.84 $8.89 $9.46 $10.38 $10.38
FCF/Share $-0.09 $-0.18 $-0.20 $-0.21 $-0.25 $-0.14 $-0.16 $-0.03 $0.06 $0.13 $0.22 $0.23 $0.38 $0.64 $0.82 $0.96 $0.47 $0.53 $0.29 $0.33 $0.33
OCF/Share $-0.07 $-0.16 $-0.17 $-0.19 $-0.22 $-0.11 $-0.13 $0.01 $0.12 $0.21 $0.35 $0.39 $0.54 $0.79 $1.04 $1.36 $1.02 $1.31 $1.22 $1.24 $1.24
Cash/Share $0.52 $0.50 $1.23 $1.22 $1.21 $1.20 $0.87 $0.87 $0.86 $0.85 $1.05 $0.96 $0.94 $0.94 $1.25 $1.22 $1.17 $1.21 $2.33 $2.53 $3.29
EBITDA/Share $-0.38 $-0.47 $-0.60 $-0.43 $-0.44 $-0.40 $-0.30 $-0.27 $-0.21 $-0.15 $-0.10 $0.01 $0.10 $0.24 $0.33 $0.54 $0.60 $0.64 $0.65 $0.44 $0.44
Debt/Share $0.00 $0.00 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.05 $0.04 $0.04 $0.04 $0.05 $0.05 $0.04 $0.05 $5.09 $5.53 $5.53
Net Debt/Share $-0.52 $-0.50 $-1.20 $-1.19 $-1.19 $-1.18 $-0.85 $-0.84 $-0.84 $-0.83 $-1.01 $-0.92 $-0.90 $-0.90 $-1.20 $-1.17 $-1.13 $-1.16 $2.77 $3.01 $3.01
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.039
Altman Z-Prime snapshot only 4.117
Piotroski F-Score 4 3 2 3 3 4 5 6 6 6 6 6 6 6 6 6 6 6 5 5 5
Beneish M-Score -4.48 -3.96 1.57 2.23 2.15 1.80 -2.65 -3.03 -3.18 -3.43 -2.71 -2.67 -2.82 -2.50 -2.75 -2.90 -2.53 -3.48 0.70 1.29 1.295
Ohlson O-Score snapshot only -5.538
ROIC (Greenblatt) snapshot only 3.90%
Net-Net WC snapshot only $-3.71
EVA snapshot only $-98034170.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A-
Credit Score 20.00 20.00 70.55 67.43 71.01 70.13 71.94 73.63 79.07 77.95 79.09 72.87 93.14 94.21 93.53 91.84 93.50 94.08 74.39 69.49 69.495
Credit Grade snapshot only 7
Credit Trend snapshot only -22.342
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 75
Sector Credit Rank snapshot only 63

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms